Loading...
XCSE
GUBRA
Market cap989mUSD
Aug 28, Last price  
388.80DKK
Name

Gubra A/S

Chart & performance

D1W1MN
XCSE:GUBRA chart
P/E
P/S
EPS
102.96
Div yield, %
15.74%
Shrs. gr., 5y
0.18%
Rev. gr., 5y
72.57%
Revenues
Net income
CFO
Dividend
Jun 30, 202561.2 DKK/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Gubra A/S is a biotechnology firm engaged in two core activities: offering contract research organization (CRO) services for pre-clinical development, and advancing its own internal early-stage drug and target discovery initiatives. Its CRO division provides specialized pre-clinical research and development support to companies in the pharmaceutical and biotechnology sectors. These services encompass a wide range of capabilities, including in vivo pharmacology, tissue analysis, various assay development, molecular pharmacology, bioanalytical testing, next-generation sequencing (NGS), and both two-dimensional and three-dimensional imaging techniques. Established in 2008, the company has its headquarters in Horsholm, Denmark.
IPO date
Apr 04, 2023
Employees
Domiciled in
DK
Incorporated in
DK

Valuation

No data to show